Seelaus Asset Management LLC cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 4.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,022 shares of the exchange traded fund’s stock after selling 217 shares during the period. Seelaus Asset Management LLC’s holdings in SPDR S&P Biotech ETF were worth $496,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Quintet Private Bank Europe S.A. bought a new position in shares of SPDR S&P Biotech ETF in the third quarter worth about $40,000. ORG Partners LLC bought a new position in SPDR S&P Biotech ETF in the 2nd quarter worth approximately $40,000. ORG Wealth Partners LLC acquired a new position in SPDR S&P Biotech ETF during the 3rd quarter worth $44,000. Waldron Private Wealth LLC bought a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at $54,000. Finally, Resources Management Corp CT ADV increased its stake in shares of SPDR S&P Biotech ETF by 30.3% in the 2nd quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock valued at $55,000 after buying an additional 138 shares during the period.
SPDR S&P Biotech ETF Stock Down 5.2 %
XBI stock opened at $91.88 on Friday. The business has a fifty day moving average of $98.95 and a 200-day moving average of $96.03. The company has a market cap of $7.00 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $69.32 and a twelve month high of $105.47.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- What is Short Interest? How to Use It
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Time to Load Up on Home Builders?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Flutter Entertainment Can Be a Blue-Chip Sports Betting Stock
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.